Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current molecular medicine

• Publication date

  2011-02-28

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.2174/156652411794859223PMID 21342129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL)

  2010cited by this paper
• Assessment of Bone Mineral Density and Risk Factors in Children Completing Treatment for Acute Lymphoblastic Leukemia

  2010cited by this paper
• Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

  2010cited by this paper
• Pattern of Relapse in Childhood ALL: Challenges and Lessons From a Uniform Treatment Protocol

  2010cited by this paper
• Mechanisms of Impaired Growth: Effect of Steroids on Bone and Cartilage

  2009cited by this paper
• The impact of risk stratification by early bone‐marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99

  2009cited by this paper
• Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK.

  2009cited by this paper
• Safety studies conducted on high-purity trans-resveratrol in experimental animals.

  2009cited by this paper
• Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.

  2009cited by this paper
• Late Effects in Long-Term Survivors After Treatment for Childhood Acute Leukemia

  2009cited by this paper
• Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma

  2009cited by this paper
• Secondary osteoporosis.

  2009cited by this paper
• New therapies for osteoporosis: Zoledronic acid, bazedoxifene, and denosumab

  2009cited by this paper
• Nutrition: its role in bone health.

  2008cited by this paper
• Hemophilia, low bone mass, and osteopenia/osteoporosis.

  2008cited by this paper
• Osteoporosis in children with cancer

  2008cited by this paper
• Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials

  2008cited by this paper
• Height deficit during and many years after treatment for acute lymphoblastic leukemia in children: A review

  2008cited by this paper
• Osteocytes, mechanosensing and Wnt signaling.

  2008cited by this paper
• Folinic acid attenuates methotrexate chemotherapy‐induced damages on bone growth mechanisms and pools of bone marrow stromal cells

  2008cited by this paper
• Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference.

  2008cited by this paper
• Apoptotic Bodies Convey Activity Capable of Initiating Osteoclastogenesis and Localized Bone Destruction

  2008cited by this paper
• Bone mineral density in young adult survivors of acute lymphoblastic leukemia

  2008cited by this paper
• Oxidative stress, free radicals and bone remodeling

  2008cited by this paper
• Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer.

  2008cited by this paper
• Skeletal toxicities of treatment in children with cancer

  2008cited by this paper
• Bone Mineral Density Deficits in Survivors of Childhood Cancer: Long-term Follow-up Guidelines and Review of the Literature

  2008cited by this paper
• Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study.

  2008cited by this paper
• The osteocyte lineage.

  2008cited by this paper
• Osteonecrosis in children and adolescents with cancer

  2008cited by this paper
• Osteonecrosis in Children Treated for Lymphoma or Solid Tumors

  2008cited by this paper
• Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference.

  2008cited by this paper
• Risks and benefits of bisphosphonates

  2008cited by this paper
• Roles of epidermal growth factor family in the regulation of postnatal somatic growth.

  2007cited by this paper
• Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.

  2007cited by this paper
• Osteonecrosis in children and adolescents with cancer - an adverse effect of systemic therapy.

  2007cited by this paper
• Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women

  2007cited by this paper
• Glucocorticoid-Induced Osteoporosis in Children: Impact of the Underlying Disease

  2007cited by this paper
• Glucocorticoid-induced osteoporosis: pathophysiology and therapy

  2007cited by this paper
• The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438.

  2007cited by this paper
• Is a School‐Based Physical Activity Intervention Effective for Increasing Tibial Bone Strength in Boys and Girls?

  2007cited by this paper
• Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?

  2007cited by this paper
• Resveratrol: From Basic Science to the Clinic

  2007cited by this paper
• Effects of etoposide and cyclophosphamide acute chemotherapy on growth plate and metaphyseal bone in rats

  2007cited by this paper
• Bisphosphonate Therapy for Reduced Bone Mineral Density During Treatment of Acute Lymphoblastic Leukemia in Childhood and Adolescence: A Report of Preliminary Experience

  2007cited by this paper
• Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells.

  2007cited by this paper
• Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis.

  2006cited by this paper
• Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy.

  2006cited by this paper
• L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death

  2006cited by this paper
• Activation of Sirt1 Decreases Adipocyte Formation During Osteoblast Differentiation of Mesenchymal Stem Cells

  2006cited by this paper
• Folate Supplementation: Too Much of a Good Thing?

  2006cited by this paper
• The role of vitamin D in cancer prevention.

  2006cited by this paper
• Glucocorticoid repression of the reproductive axis: effects on GnRH and gonadotropin subunit mRNA levels.

  2006cited by this paper
• High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia

  2006cited by this paper
• Cancer-treatment-induced bone loss, part 2.

  2006cited by this paper
• Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.

  2006cited by this paper
• Osteocytes—martyrs for integrity of bone strength

  2006cited by this paper
• Damage and recovery of the bone growth mechanism in young rats following 5‐fluorouracil acute chemotherapy

  2006cited by this paper
• Does Alendronate Prevent Collapse in Osteonecrosis of the Femoral Head?

  2006cited by this paper
• Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.

  2006cited by this paper
• Therapeutic potential of resveratrol: the in vivo evidence

  2006cited by this paper
• Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting.

  2005cited by this paper
• Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3'-kinase signaling pathway.

  2005cited by this paper
• Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.

  2005cited by this paper
• Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study

  2005cited by this paper
• OSTEOPOROSIS AT PRESENTATION OF CHILDHOOD ALL

  2005cited by this paper
• How to manage osteoporosis in children.

  2005cited by this paper
• Skeletal morbidity in childhood acute lymphoblastic leukemia.

  2004cited by this paper
• Bone Turnover and Growth during and after Chemotherapy in Children with Solid Tumors

  2004cited by this paper
• Effects of methotrexate on human bone cell responses to mechanical stimulation.

  2004cited by this paper
• Amifostine for children with medulloblastoma treated with cisplatin‐based chemotherapy

  2004cited by this paper
• Dexamethasone inhibits insulin‐induced chondrogenesis of ATDC5 cells by preventing PI3K‐Akt signaling and DNA binding of Runx2

  2004cited by this paper
• Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB.

  2004cited by this paper
• Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.

  2004cited by this paper
• Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness

  2004cited by this paper
• Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

  2004cited by this paper
• Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents

  2004cited by this paper
• Augmentation of Chemotherapy-Induced Cytokine Production by Expression of the Platelet-Activating Factor Receptor in a Human Epithelial Carcinoma Cell Line1

  2004cited by this paper
• Prevention of Glucocorticoid‐Induced Apoptosis in Osteocytes and Osteoblasts by Calbindin‐D28k

  2003cited by this paper
• Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.

  2003cited by this paper
• A crucial role for thiol antioxidants in estrogen-deficiency bone loss.

  2003cited by this paper
• Roles of growth factors in chemotherapy-induced intestinal mucosal damage repair.

  2003cited by this paper
• The effect of chemotherapy on the morphology of the growth plate and metaphysis of the growing skeleton.

  2003cited by this paper
• Bone mineral density in long-term survivors of highly malignant osteosarcoma.

  2003cited by this paper
• Systemic and local regulation of the growth plate.

  2003cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.

  2002cited by this paper
• Effects of Chemotherapy on Bone Metabolism and Skeletal Growth

  2002cited by this paper
• In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy.

  2002cited by this paper
• Management of corticosteroid-induced osteoporosis.

  2002cited by this paper
• Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.

  2002cited by this paper
• Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development

  2001cited by this paper
• Skeletal effects of short-term prednisolone therapy in children with steroid-responsive nephrotic syndrome

  2001cited by this paper
• High‐dose chemotherapy shows a dose‐dependent toxicity to bone marrow osteoprogenitors

  2001cited by this paper
• Association between oxidative stress and bone mineral density.

  2001cited by this paper
• Amifostine before fractionated irradiation protects bone growth in rats better than fractionation alone.

  2001cited by this paper
• Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.

  2000cited by this paper
• Bone Turnover and Growth During and After Continuing Chemotherapy in Children with Acute Lymphoblastic Leukemia

  2000cited by this paper
• Basis for effective combination cancer chemotherapy with antimetabolites.

  2000cited by this paper
• Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation1

  2000cited by this paper

• Multi-modal investigation of doxorubicin-induced osteoporosis: Network toxicology, machine learning, and imaging techniques

  2025cites this paper
• Melatonin and Metformin Mitigate Doxorubicin-Induced Alveolar Bone Toxicity

  2024cites this paper
• Methotrexate Chemotherapy Causes Growth Impairments, Vitamin D Deficiency, Bone Loss, and Altered Intestinal Metabolism—Effects of Calcitriol Supplementation

  2023cites this paper
• Préservation épiphysaire et reconstruction biologique après résection de sarcome de membre chez l’enfant : fonction articulaire et croissance

  2023cites this paper
• Epiphyseal-sparing biological reconstruction of bone sarcoma in children: focus on articular function and growth.

  2022cites this paper
• Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved

  2021cites this paper
• The Dental Implant Maintenance

  2021cites this paper
• Roles of apoptotic chondrocyte‐derived CXCL12 in the enhanced chondroclast recruitment following methotrexate and/or dexamethasone treatment

  2021cites this paper
• Role of MRI in the Detection and Monitoring of Lower Limb Osteonecrosis after Chemotherapy in Pediatric Patients with Acute Lymphoblastic Leukaemia

  2020cites this paper
• Non-neurologic Late Effects of Therapy

  2019cites this paper
• Release of CXCL12 From Apoptotic Skeletal Cells Contributes to Bone Growth Defects Following Dexamethasone Therapy in Rats

  2019cites this paper
• The changes of standard DXA measurements and TBS depending on outcomes of neurosurgical treatment in patients with Cushing's disease

  2019cites this paper
• Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats

  2018cites this paper
• Effects of Differently Processed Rehmannia Roots on Dexamethasone-induced Side Effects in Rats

  2018cites this paper
• Strain-specific differences in the development of bone loss and incidence of osteonecrosis following glucocorticoid treatment in two different mouse strains

  2018cites this paper
• Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery

  2018cites this paper
• Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss

  2017cites this paper
• Protective role of benzoselenophene derivatives of resveratrol on the induced oxidative stress in intestinal myofibroblasts and osteocytes.

  2017cites this paper
• Childhood cancer chemotherapy–induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals

  2017cites this paper
• Effect of Vitamin D Supplementation on Delayed Hyperphosphatemia in Pediatric Acute Lymphoblastic Leukemia Patients During Induction Chemotherapy.

  2017cites this paper
• Lower-limb MRI in the staging and re-staging of osteonecrosis in paediatric patients affected by acute lymphoblastic leukaemia after therapy

  2016cites this paper
• Steamed root of Rehmannia glutinosa Libosch (Plantaginaceae) alleviates methotrexate-induced intestinal mucositis in rats.

  2016cites this paper
• Reconstruction After Tumor Resection in the Growing Child.

  2016cites this paper
• Late endocrine effects of childhood cancer

  2016cites this paper
• Nutlin‐3 treatment spares cisplatin‐induced inhibition of bone healing while maintaining osteosarcoma toxicity

  2016cites this paper
• Protective mechanisms of resveratrol against methotrexate‐induced renal damage may involve BCRP/ABCG2

  2016cites this paper
• Methotrexate chemotherapy triggers touch-evoked pain and increased CGRP-positive sensory fibres in the tibial periosteum of young rats.

  2015cites this paper
• Wachstum und Knochenstoffwechsel nach onkologischer Erkrankung im Kindes- und Jugendalter

  2015cites this paper
• Assessment of Fundamental Movement Skills in Childhood Cancer Patients

  2015cites this paper
• Bone mineral density among long‐term survivors of childhood acute lymphoblastic leukemia: Results from the St. Jude Lifetime Cohort Study

  2014cites this paper
• Potential roles of metallothioneins I and II in protecting bone growth following acute methotrexate chemotherapy

  2014cites this paper
• Paley’s Multiplier Method Does Not Accurately Predict Adult Height in Children with Bone Sarcoma

  2014cites this paper
• Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia

  2014cites this paper
• Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL)

  2014cites this paper
• Antibody-targeted immunoliposomes for cancer treatment.

  2013cites this paper
• Bone Mineral Density Deficits and Fractures in Survivors of Childhood Cancer

  2013cites this paper
• Children are not large mice

  2013cites this paper
• Growth Factors , Cytokines , and Cell Cycle Molecules Methotrexate Chemotherapy Promotes Osteoclast Formation in the Long Bone of Rats via Increased Pro-Inflammatory Cytokines and Enhanced NF-B Activation

  2012cites this paper
• Prevention of Bone Growth Defects, Increased Bone Resorption and Marrow Adiposity with Folinic Acid in Rats Receiving Long-Term Methotrexate

  2012cites this paper
• Bone Marrow Osteoblast Damage by Chemotherapeutic Agents

  2012cites this paper
• Understanding Injury, Health, and Adaptations of the Musculoskeletal System

  2012cites this paper
• Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation.

  2012cites this paper
• Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.

  2011cites this paper
• Rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease.

  2011cites this paper